Eosinophilic disorders in children

Amy Wagelie-Steffen1, Seema S Aceves

  • 1Division of Allergy, Immunology, Children's Hospital of San Diego, 3020 Children's Way MC-5114, San Diego, CA 92123, USA.

Insights

Pediatric eosinophilic disorders, including asthma and eosinophilic esophagitis, involve eosinophil-driven tissue damage. New biologic therapies offer hope, but understanding disease progression and treatment remains crucial.

Area of Science:

  • Pediatric Allergy and Immunology
  • Gastroenterology
  • Hematology

Background:

  • Eosinophilia is a hallmark of various pediatric diseases, ranging from common atopic conditions like asthma to rarer disorders such as hypereosinophilic syndrome and eosinophilic gastrointestinal disorders.
  • Eosinophil activity in affected organs causes tissue damage, initiating repair processes that can lead to long-term structural and functional changes.

Purpose of the Study:

  • To review the current understanding of pediatric eosinophilic disorders.
  • To highlight recent advancements in therapeutic options.
  • To emphasize the ongoing need for research into pathogenesis, diagnosis, treatment, and natural history.

Main Methods:

  • Literature review of pediatric eosinophilic disorders.
  • Analysis of current treatment modalities, including biologic agents.
  • Discussion of disease mechanisms and clinical presentation.

Main Results:

  • Eosinophilic disorders are increasingly diagnosed in children.
  • Biologic agents like tyrosine kinase inhibitors and anti-interleukin-5 show promise in treating specific eosinophilic conditions.
  • Significant knowledge gaps persist regarding optimal management and long-term outcomes.

Conclusions:

  • Pediatric eosinophilic disorders represent a significant clinical challenge.
  • Targeted therapies are emerging, but a comprehensive understanding is still developing.
  • Further research is essential to improve patient care and outcomes for these conditions.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...